Novo Nordisk's pricing procedures inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of value gouging, stating the stark distinction involving U.S. costs and people in Europe and copyright. Rybelsus and copyright triggered thyr